FCM
PFE icon

Farallon Capital Management’s Pfizer PFE Stock Holding History

Farallon Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-1,059,270
Closed -$29.8M – 92
2014
Q2 		$29.8M Buy
+1,059,270
New +$30.2M 0.43% 49
2013
Q3 		– Sell
-1,367,037
Closed -$36.3M – 83
2013
Q2 		$36.3M Buy
+1,367,037
New +$37.8M 0.7% 38

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Farallon Capital Management's PFE Position: Q3 2014 in Review

Farallon Capital Management sold out of Pfizer (PFE) in Q3 2014, closing a stake of 1,059,270 shares — an estimated $29.8M sold.

Farallon Capital Management first reported a position in PFE in Q2 2013 and held it in 2 quarters. The position peaked at $36.3M in Q2 2013. 1,742 funds tracked by Wall St. Rank hold PFE as of Q3 2014.

  • Farallon Capital Management reported no remaining Pfizer position as of Q3 2014 after selling out during the quarter.
  • Farallon Capital Management sold 1,059,270 Pfizer shares in Q3 2014, an estimated $29.8M.
  • Farallon Capital Management first reported a position in Pfizer in Q2 2013 and held it in 2 quarters.
  • Farallon Capital Management's Pfizer position peaked at $36.3M in Q2 2013.
  • 1,742 funds tracked by Wall St. Rank held Pfizer as of Q3 2014.

Based on Farallon Capital Management's 13F filing for Q3 2014, filed 14 Nov 2014.